Global medical nitrile glove market forecast at $11.5 billion by 2033

Pune, India – The Brainy Insights projects that the global medical nitrile gloves market, valued at USD 4 billion in 2023, will grow to USD 11.35 billion by 2033.

Medical nitrile gloves are a crucial part of personal protective equipment (PPE) used in healthcare settings. These gloves are made from nitrile butadiene rubber (NBR), a synthetic rubber known for its high durability, chemical resistance, and hypoallergenic properties. Unlike latex gloves, nitrile gloves do not contain latex proteins, making them suitable for individuals with latex allergies. The manufacturing process involves combining raw materials to create the nitrile compound, which is then molded and vulcanized to enhance its strength and durability. Nitrile gloves are highly resistant to punctures, tears, and a wide range of chemicals, making them ideal for handling hazardous substances while providing a durable barrier against diseases and pollutants. These gloves are designed to offer a comfortable fit and exceptional dexterity. Medical nitrile gloves are essential for protecting against infectious diseases, toxic chemicals, and other hazards in professional settings. Their durability, chemical resistance, and hypoallergenic properties ensure the safety and well-being of users and patients across various industries.

The region’s high demand for nitrile gloves is driven by its expansive healthcare sector, stringent safety regulations, and strong focus on infection control. North American manufacturers are known for their technological advancements in glove production, investing significantly in research and development to create innovative materials, production methods, and designs. This results in nitrile gloves that are high-performing, durable, and comfortable. Adherence to strict regulatory standards boosts consumer confidence in North American-made nitrile gloves, both domestically and internationally.
In 2023, the non-powdered segment led the market with a 72% share and revenue of USD 2.88 billion.

The product type segment includes powdered and non-powdered gloves. In 2023, the non-powdered segment dominated, securing a 72% market share and generating USD 2.88 billion in revenue.

In 2023, the hospital segment led the market with a 62% share and revenue of USD 2.48 billion.
The end-user segment comprises hospitals, laboratories, and other settings. In 2023, the hospital segment was the largest, capturing a 62% market share and generating USD 2.48 billion in revenue.

Phu Duc Huy US Inc., a Vietnamese glove manufacturer, plans to purchase 15 acres in Lake Village, southeast Arkansas, for a new facility that will eventually employ up to 300 people. The company is negotiating the land purchase, which is expected to cost around $400,000, to establish a nitrile glove manufacturing plant. These powder-free, non-latex gloves are commonly used in the medical industry and by the Department of Defense. Additionally, Phu Duc Huy will lease and utilize an existing warehouse on the site for storage.

The global medical nitrile gloves market is dominated by several key companies, including: Ansell Healthcare LLC, Atrium Medical Care, Hartalega Holdings, Honeywell International Inc., Kimberly-Clark, McKesson Corporation, Mercator Medical S.A., Shield Scientific, Supermax Healthcare, Top Glove Corporation
The market analysis is conducted based on value in USD billion, covering global, regional, and country-level segments. The study includes analysis across more than 30 countries for each segment, examining driving factors, opportunities, constraints, and challenges to provide essential market insights. It incorporates analytical tools such as Porter’s five forces model, attractiveness analysis, product analysis, supply and demand analysis, competitor position grid analysis, distribution analysis, and marketing channels analysis.